Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Treos Bio Limited
- Study ID
- NCT05243862
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
- Colorectal Cancer Metastatic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- PolyPEPI1018 — DRUGPolyPEPI1018 vaccine contains 6 synthetic peptides emulsified with the adjuvant Montanide™. The peptides were selected to induce T cell responses against 12 dominant epitopes from 7 tumor-specific antigens, which are the most frequently expressed antigens in colorectal cancer.
- Atezolizumab — DRUGAtezolizumab is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1.
Study Details
This is a multicenter, open label, phase II trial to determine the safety, tolerability, and immunogenicity and initial clinical activity of the combination treatment of PolyPEPI1018 vaccine and atezolizumab in participants with MSS CRC who have progressed on 2 or 3 prior regimens.
Key Dates
- Start date
- Jun 2, 2022
- Status verified
- Nov 2024
- Primary completion
- Jul 8, 2024
- Completion
- Jun 2, 2026
Study Design
- Enrollment
- 18 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: PolyPEPI1018 plus AtezolizumabParticipants receive every 3 weeks PolyPEPI1018 CRC Vaccine (Emulsified solution, 0.2 mg/peptide, 6 peptides total, and Montanide™ ISA51VG adjuvant), by SC injection in combination with Atezolizumab (Injectable solution,1200mg/20mL) by IV injection.
Primary Outcome Measure
The incidence and severity treatment related Adverse Events [ Time Frame: From 1st dose until 90-Days after last dose ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Phoenix | Arizona | 85054 | - |
| Mayo Clinic | Jacksonville | Florida | 32224 | - |
| Mayo Clinic | Rochester | Minnesota | 55905 | - |
Find similar trials in Phoenix, AZ
Related Studies
- Medical Cannabis in Patients With Advanced Pancreatic and Colorectal CancerPHASE2 · Recruiting · HealthPartners Institute · Saint Louis Park, Minnesota
- Living Donor Liver Transplant for Unresectable Colorectal Liver MetastasesRecruiting · University of Rochester · Rochester, New York
- Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver MetastasesPHASE2 · Recruiting · Weill Medical College of Cornell University · New York, New York
- Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)PHASE2 · Recruiting · Buzzard Pharmaceuticals · Los Angeles, California